Catherine Jacobson - May 22, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
May 22, 2024
Transactions value $
$0
Form type
4
Date filed
5/24/2024, 04:25 PM
Previous filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +9.83K +93.07% 20.4K May 22, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -9.83K -100% $0.00* 0 May 22, 2024 Common Stock 9.83K Direct F2, F3
transaction TDOC Restricted Stock Units Award $0 +17.5K $0.00 17.5K May 23, 2024 Common Stock 17.5K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024.
F4 The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders.